Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment
Authors
Keywords
Cardiomyopathy, Left ventricular hypertrophy, Enzyme replacement therapy, Cardiac MRI
Journal
HEART FAILURE REVIEWS
Volume 20, Issue 2, Pages 179-191
Publisher
Springer Nature
Online
2014-07-16
DOI
10.1007/s10741-014-9452-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene Mutations Versus Clinically Relevant Phenotypes: Lyso-Gb3 Defines Fabry Disease
- (2014) M. Niemann et al. Circulation-Cardiovascular Genetics
- Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis
- (2014) Saskia M. Rombach et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Outcomes of patients treated through the Canadian Fabry disease initiative
- (2014) S.M. Sirrs et al. MOLECULAR GENETICS AND METABOLISM
- Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease
- (2013) Yoshiyuki Suzuki BRAIN & DEVELOPMENT
- Progression of Fabry Cardiomyopathy Despite Enzyme Replacement Therapy
- (2013) Maurizio Pieroni et al. CIRCULATION
- Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping
- (2013) Daniel M. Sado et al. Circulation-Cardiovascular Imaging
- T 1 Mapping With Cardiovascular MRI Is Highly Sensitive for Fabry Disease Independent of Hypertrophy and Sex
- (2013) Richard B. Thompson et al. Circulation-Cardiovascular Imaging
- Neurological Complications of Anderson-Fabry Disease
- (2013) Antonino Tuttolomondo et al. CURRENT PHARMACEUTICAL DESIGN
- Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries
- (2013) Clara K. Chow JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fabry Disease Practice Guidelines: Recommendations of the National Society of Genetic Counselors
- (2013) Dawn A. Laney et al. Journal of Genetic Counseling
- Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study
- (2013) Takahito Inoue et al. JOURNAL OF HUMAN GENETICS
- Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications
- (2013) F. Weidemann et al. JOURNAL OF INTERNAL MEDICINE
- A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance
- (2013) L van der Tol et al. JOURNAL OF MEDICAL GENETICS
- The MOGE(S) Classification for a Phenotype–Genotype Nomenclature of Cardiomyopathy
- (2013) Eloisa Arbustini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Systolic and Diastolic Function Assessment in Fabry Disease Patients Using Speckle-Tracking Imaging and Comparison with Conventional Echocardiographic Measurements
- (2013) Miriam Shanks et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- In the Thick of It
- (2013) Deepak A. Rao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exercise Response in Hypertrophic Cardiomyopathy
- (2012) Camille Soullier et al. Circulation-Cardiovascular Imaging
- Arrhythmias in Fabry Cardiomyopathy
- (2012) Deepak Acharya et al. CLINICAL CARDIOLOGY
- The Dietary Approaches to Stop Hypertension (DASH) Eating Pattern in Special Populations
- (2012) Crystal C. Tyson et al. CURRENT HYPERTENSION REPORTS
- Prevalence of Obesity and Trends in Body Mass Index Among US Children and Adolescents, 1999-2010
- (2012) Cynthia L. Ogden et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010
- (2012) Katherine M. Flegal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- α-Galactosidase Aggregation Is a Determinant of Pharmacological Chaperone Efficacy on Fabry Disease Mutants
- (2012) Aleksandra Siekierska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria
- (2012) Thomas P Mechtler et al. LANCET
- Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice
- (2012) Elfrida R Benjamin et al. MOLECULAR THERAPY
- Small biotechs raring to cash in on the orphan disease market
- (2012) Rebecca Hersher NATURE MEDICINE
- Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy
- (2012) Aritz Perez Ruiz de Garibay et al. Drug Design Development and Therapy
- The Molecular Basis of Pharmacological Chaperoning in Human α-Galactosidase
- (2011) Abigail I. Guce et al. CHEMISTRY & BIOLOGY
- Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey
- (2011) P. Elliott et al. HEART
- A pharmacogenetic approach to identify mutant forms of α-galactosidase a that respond to a pharmacological chaperone for Fabry disease
- (2011) Xiaoyang Wu et al. HUMAN MUTATION
- MR-based analysis of regional cardiac function in relation to cellular integrity in Fabry disease
- (2011) Sabrina Koeppe et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Exercise-Induced Left Ventricular Outflow Tract Obstruction in Symptomatic Patients With Anderson-Fabry Disease
- (2011) Margherita Calcagnino et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Assessment of Myocardial Fibrosis With Cardiovascular Magnetic Resonance
- (2011) Nathan Mewton et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diagnostic dilemma: A young woman with Fabry disease symptoms, no family history, and a “sequencing cryptic” α-galactosidase a large deletion
- (2011) Ulla Feldt-Rasmussen et al. MOLECULAR GENETICS AND METABOLISM
- Role of cardiac MRI in evaluating patients with Anderson-Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy
- (2011) G. Messalli et al. Radiologia Medica
- Differences in Fabry Cardiomyopathy Between Female and Male Patients
- (2011) Markus Niemann et al. JACC-Cardiovascular Imaging
- When Should Cardiologists Suspect Anderson-Fabry Disease?
- (2010) Fabiana I. Gambarin et al. AMERICAN JOURNAL OF CARDIOLOGY
- Pseudodeficiency of α-galactosidase A
- (2010) Gideon Bach et al. CLINICAL GENETICS
- Dialysis and Transplantation in Fabry Disease: Indications for Enzyme Replacement Therapy
- (2010) R. Mignani et al. Clinical Journal of the American Society of Nephrology
- Prognostic Indicators of Renal Disease Progression in Adults with Fabry Disease: Natural History Data from the Fabry Registry
- (2010) C. Wanner et al. Clinical Journal of the American Society of Nephrology
- Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and -galactosidase A activity
- (2010) J. C. Wu et al. EUROPEAN HEART JOURNAL
- Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women
- (2010) Ole Havndrup et al. EUROPEAN JOURNAL OF HEART FAILURE
- Promoter-specific lentivectors for long-term, cardiac-directed therapy of Fabry disease
- (2010) Chyan-Jang Lee et al. Journal of Cardiology
- Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy
- (2009) Frank Weidemann et al. CIRCULATION
- Cardiac Microvascular Pathology in Fabry Disease
- (2009) Beth L. Thurberg et al. CIRCULATION
- High Incidence of the Cardiac Variant of Fabry Disease Revealed by Newborn Screening in the Taiwan Chinese Population
- (2009) Hsiang-Yu Lin et al. Circulation-Cardiovascular Genetics
- Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey
- (2009) A Mehta et al. JOURNAL OF MEDICAL GENETICS
- Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data
- (2009) A Mehta et al. LANCET
- Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations
- (2009) B. Oqvist et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cardiac manifestations of Anderson-Fabry disease in children and adolescents
- (2008) Christoph Kampmann et al. ACTA PAEDIATRICA
- Clinical usefulness of tissue Doppler imaging in predicting preclinical Fabry cardiomyopathy
- (2008) Rocio Toro et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Prediction of response of mutated alpha-galactosidase A to a pharmacological chaperone
- (2008) Sang H. Shin et al. Pharmacogenetics and Genomics
- Elevated globotriaosylsphingosine is a hallmark of Fabry disease
- (2008) J. M. Aerts et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ocular Features of Fabry Disease: Diagnosis of a Treatable Life-threatening Disorder
- (2008) Nasi Samiy SURVEY OF OPHTHALMOLOGY
- Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry
- (2007) William R. Wilcox et al. MOLECULAR GENETICS AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search